Trial NCT01363349

View at ClinicalTrials.gov 
Aliases: NCT01365299
Org. Study IDs: 1020-CLIN-201

Last trial update was posted on 2014-09-18

MeSH Interventions

Risperidone

MeSH Conditions

Schizophrenia

Other Conditions

Cognitive Effect on Schizophrenic Patients

Stopping Reasons

pre-planned interim analysis of the Phase II/III CLARITY trial of BL-1020 indicate that the trial would not meet the pre-specified primary efficacy endpoint.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID